Year-end Report 2008

Thu. February 12, 2009; Posted: 03:02 AM

Feb 12, 2009 (Hugin via COMTEX) -- BGAIF | Quote | Chart | News | PowerRating -- Press Release, 12 February, 2009 (13 pages) BioGaia AB Year-end Report 2008 (Figures in brackets refer to the same period of last year) * Net sales amounted to SEK 145.2 million (106.6), an increase of SEK 38.6 million (36%) compared to the previous year. * Operating profit was SEK 25.8 million (8.9), up by SEK 16.9 million compared to the previous year. * Profit before tax was SEK 24.0 million (10.7), an improvement of SEK 13.3 million compared to the previous year. This figure includes an unrealised foreign exchange loss of SEK 4.5 million on forward exchange contracts. * Profit after tax was SEK 36.1 million (19.7), an increase of SEK 16.4 million compared to the previous year. Profit for the period includes a deferred tax benefit of SEK 12.1 million (9.0). * Earnings per share were SEK 2.10 (1.14). * The year's cash flow from operating activities before change in working capital was SEK 32.4 million (15.8). Total cash flow for the year was SEK 14.3 (3.3). Cash and cash equivalents at 31 December 2008 amounted to SEK 58.1 million (43.0). * The Board proposes to the upcoming AGM that a dividend be paid to the shareholders.

Key events in the fourth quarter of 2008 * BioGaia invests in LifeTop Cap through new subsidiary - CapAble AB. * New study confirms that BioGaia's oral health products counteract gingivitis. * Agreement with Delta Medical for the sale of BioGaia's Probiotic drops and tablets in Kazakhstan and tablets in Ukraine. * Agreement with Ferring for the sale of BioGaia's Probiotic drops in Ireland and drops and tablets in the Middle East. * Delivery of LifeTop Straw to China started. * BioGaia's subsidiary CapAble signs agreement with Mass Probiotics for the sale of LifeTop Cap in North America.

Key events after the end of the financial year * BioGaia's subsidiary CapAble signs agreement with Aqua Scandik for the sale of LifeTop Cap with Reuteri in Mexico.

"I am very pleased with BioGaia's continued sales growth and dramatic increase in earnings during the past year, which has motivated the Board to propose payment of a shareholder dividend. Because of our strong financial position, this limited capital outflow will not affect our opportunities for expansion. We are seeing sustained strong demand for our products and expect to launch our products in many new countries during 2009," says President Peter Rothschild.

Latest press releases from BioGaia: 2009-01-12 CapAble signs agreement in Mexico 2008-12-19 BioGaia's subsidiary CapAble signs agreement for LifeTop(TM) Cap in North America 2008-12-15 BioGaia signs distribution agreement for Ireland and Middle East

For additional information contact Peter Rothschild, President, telephone: +46 8 -555 293 00 Jan Annwall, Executive Vice President, telephone: +46 8 - 555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the Nasdaq OMX Nordic Exchange Stockholm. www.biogaia.se

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

SOURCE: BioGaia AB

For full details for BGAIF click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.